Dr. David Samadi: the future of Urology

Dr. David Samadi is a certified urologist majoring in diagnosing as well as treating diseases such as Prostate Cancer, cancer affecting the kidney as well as Bladder cancer. He also deals in urologic illnesses. He is somewhat a celebrity in his way and accord. He is adverse to treatments that are rarely invasive for Prostate Cancer. These techniques include Laparoscopic Radical Prostatectomy as well as Laparoscopic Robotic Radical Prostatectomy.

He was born in Iran. He was born in an area inhabited by Jews of Persian descent. He was born in the year 1964. He was brought up with the ways of the Hebrews. He is a legal US citizen as he has his nationality as an American. He is married with two kids.

In 1979 when he was 15, he fled to Belgium with his younger sibling. They later immigrated to the US in 1984 from London. They were separated ever since from their parents and sister called Heidi. Though separate everything was paid by their parents.

In Northern London, he studied in Golders Green. He pursued his high school life at Roslyn High School, New York. He then did a Bachelor’s degree in Biochemistry in Stony Broke University on a fully paid scholarship program. He did his thesis Stony Brook School of Medicine. He later completed his post-university degree at Montefiore Medical Center pursuing Urology. He accomplished his training under the same specialization at the Albert Einstein College of Medicine located in the Bronx, New York as well as the Montefiore Medical Center 4 years later. He then finished a fellowship on Proctology, which is a field in oncology, from the Memorial Sloan-Kettering Cancer Center. He, later on, completed a prostatectomy session in France at the Henri Mondor Hospital under the guidance of Professor Claude Abbou. He was given the position in the Department of Urology as the Chief of the Division of Robotics at the Mt. Sinai Medical Center.

Dr. David Samadi has done a large number of procedures and also teaches other doctors in his field on how to operate the da Vinci robotic surgical system. He is a board member of the Medical Advisory Board in Pinnacle Care International. He is also the founding father as well as a director of the Mount Sinai Robotic fellowship.

He is a host at Fox News in a show called Sunday House Call having worked there for half a decade. He also has a health blog as well.

Dr. David Samadi has achieved numerous awards and recognition in his name. Some include the Best Neurologist Award, Patient’s Choice Awards, America’s as well as New York’s Top Doctors awards, Community Partner Award, Most Compassionate Doctor Award as well as Castle Connolly Top Doctors Award. He was also featured in the New York Magazine as being among the best doctors.

To know more visit @: www.linkedin.com/in/davidsamadi

Find Out How Working for CTCA can Benefit Your Life

A career is more than just simply a job that earns a paycheck. A career challenges individuals to pursue their goals and future plans. Find out how working for CTCA can benefit your life. Along with a superior and highly competitive pay scale, Cancer Treatment Centers of America offers many finer benefits that most other ordinary employers don’t have. These include outstanding health benefits that pay well for health and medical benefits, plus the organization provides additional top paying vision and dental care benefits too. The employees hired by CTCA additionally have the options of choosing to participate in lucrative savings plans and retirement benefit packages that are better than most other healthcare businesses.

Along with substantial monetary and health benefits, working for Cancer Treatment Centers of America provides a sensational workplace environment that includes the employees in major decisions that can affect their future jobs. The top staff management teams at CTCA values every employee, and they often welcome employee input to make the work environment healthier and the patient care more productive and satisfactory. Workers at Cancer Treatment Centers of America are impressed by the wonderful treatment that they receive from top level administration personnel department staff members as well.

The rewards of caring for individuals that might not have much hope in their health crisis situations are especially grateful for the staff that work with them tirelessly and cheerfully each and every day. Since Cancer Treatment Centers of America works in a team approach business model, each important and highly valuable member of the team feels empowered, and this feeling encourages each staff member to speak up if they have a better idea on how to deliver even more exceptional patient care. This method of providing awesome patient care encourages each member of the healthcare team everyday.

CTCA Offering a Healing and Supportive Environment for Cancer Patients and More Cancer Posts on WebMD

CTCA is still offering a healing and supportive environment for cancer patients. and this organization is also offering more posts on WebMD for learning purposes. Cancer Treatment Centers of America has never shied away from those conversations that become necessary after a cancer diagnosis. Increased knowledge often results in less anxiety for the patients. Those fears of the unknown are often the hardest to manage because there isn’t something concrete to address. CTCA offers a unique healing environment, truthful cancer education and a wonderfully supportive environment that can lesson those anxious thoughts and provide substantial relief. Many support modes are available to CTCA patients and their scared family members.

Cancer Treatment Centers of America has been on the forefront of cancer treatment for many decades. The staff working at these unbelievably positive hospitals offer more than just the standard cancer procedures, treatments and drug therapies. These caring healthcare providers offer compassion and support. CTCA organizes their cancer care approaches to ensure a better outcome for each patient. A team made up of muti-discipline groups works together through the cancer treatment program providing exceptional cohesive cancer care typically not available elsewhere. This combined effort serves to decrease the need for exhaustive travel and explanation headaches that some cancer patients have to endure when their care team is spread out. CTCA offers many care options that are all available right under the same roof for added patient and family convenience.

With this option, patients can work on getting stronger and better instead of worrying about getting to specific multiple treatment appointments. Cancer Treatment Centers of America has built up strong community ties with other cancer care supportive providers like cancer support groups, home care and therapists. These extra support people are equipped to guide patients through the sometimes complex cancer treatment and aftercare programs.Every patient that enters CTCA’s doors is offered the latest in cancer treatment care and unconditional support. Having someone there to talk with can release that stress that many cancer patients are carrying by themselves. As patients receive the information, they are less afraid of what the future holds for them. Cancer Treatment Centers of America will never give up hope on any patient. This organization fights everyday for those afflicted by this taxing disease. CTCA feels that relevant cancer education is helping in this fight to end cancer deaths. The hope felt in CTCA’s hospitals is encouraging.

Patients Receive Compassionate Care Through Cancer Treatment Centers of America

Cancer Treatment Centers of America have taken a compassionate approach when it comes to treating their patients. They understand the stress and anxiety patients go through when they receive their diagnosis. One of the treatments CCTCA has to offer is immunotherapy which uses the body’s own immune system to combat cancer.

Cancer can form when the immune system begins to malfunction or break down, but those same defenses are also tools to combat the patient’s disease. Referred to as biotherapy or biological therapy, the immune system is stimulated to attack cancer cells or is provided with antibodies to combat the disease. The monoclonal antibodies are manmade versions the immune system proteins use to attack a specific part of a cancer cell.

This is different from cancer vaccines since they trigger the immune system and in response to counteracting the cancer cells. The therapy can also be used to simply stimulate the immune system so the patient’s own biological defenses can be increased to perform a certain activity that will help to discourage cell cancer growth.

Alongside treatments geared towards treating a patient’s disease, CTCA provides whole-person care to all of their patients. Their goal is to improve the quality of life for their patients and this includes helping to relieve the symptoms that come along with some of the treatments. Depression is one of the most common when a patient receives their diagnosis. Depression has been known to sap the energy out of a patient when they have a lingering sense of despair and loss. It can be difficult for them to continue treatment when the long road that lays before them is uncertain. Focusing on treating symptoms helps patients to maintain their hope and the CTCA even provides spiritual support through different therapies. This helps their patients to have the strength too keep moving forward and to improve their quality of life.

Dr. David Samadi Helps People Find a New Way to Look After Their Health

It’s no secret that it takes a long time to become a doctor. People seldom consider just how much knowledge is earned during that period. And once a medical doctor begins practicing he’ll continue to learn and innovate. This means that doctors have a wealth of knowledge that the average person lacks.

While people seldom notice that difference in knowledge, doctors know how much of a problem it can be. That’s why some of the leading figures in the medical industry are working hard to promote better understanding of health and medicine. The bigger the name the more significant the news. That’s why the news that Dr. David Samadi has found a new way to educate the public is so exciting.

Dr. David Samadi is hosting a new show called Sunday Housecall. The show is intended to help people get a better idea of what’s involved with modern medicine. The basic foundation of the show involves Dr. David Samadi teaching the audience about various medical topics. But the key defining point of the show is that it’s primarily an interactive process. The audience is always able to reach out and ask questions. Likewise other viewers will be able to benefit from those answers as well. If one person has a question it’s fairly safe to assume that others will too. This discussion format acts as a perfect way to educate the public on some very complex subjects.

Dr. David Samadi also brings in experts within various fields to get their take on the latest news from the medical world. This two tiered method of discussing medicine offers quite a few advantages for viewers. Dr. Samadi is able to act as quality control for the flow of information. He’s a fantastic public speaker who also possesses expertise in the field. As such, he can make sure that any guests live up to those standards as well. In doing so the audience has the advantage of always hearing from the experts in any given field of medicine.

Of course all of that hinges on the expertise of Dr. David Samadi himself. The doctor was offered the position for good reason. He’s a practicing physician, operating out of Lenox Hill Hospital. In that position he’s responsible for a wide range of duties. This extends all the way up to overseeing the robotics surgery program. The continuing integration of robots within medical care is about as cutting edge as medicine gets, and learn more about Dr. Samadi.

Part of what made Dr. Samadi so successful within the field is an understanding of how various schools of medicine can work together. For example, he quickly integrated his work with robotics into standard patient care. Doing so streamlines the surgical process while also providing real world feedback for the devices. This ability to push technologies and techniques into different fields is part of what makes him such a good host. He understands exactly how to take information from the medical world and translate it into something the public can understand, and http://reporterexpert.com/weekly-medical-insight-dr-david-samadi/.

The Success of Clay Siegall

Clay Siegall is an innovator and a businessman who was tested and found a new way to treat not only the many harmful and deadly cancerous side effects, but also how to treat cancer itself without ever having to use harmful radiation or chemicals in the process of eliminating the cancer cells. Clay Siegall is the founder of Seattle Genetics that was founded in 1998 to offer individuals with cancerous cells in all stages a new and cheaper alternative to the treatment. Clay Siegall has proved himself to be a top leader and innovator of the company who has involved himself with all of the discoveries of the company and is the force behind the innovation that is shown through this company and the results that this company provides to the customers. Mr. Siegall has demonstrated his capability with the product and has secured almost $700 million in private as well as public investments.

Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors

In recent news, Clay Siegall was honored with a new position to be appointed to the board of directors for Mirna Therapeutics as he has shown his excellence within the business industry in addition to his excellence that has been shown in the industry of biotechnology. Dr. Siegall will be a distinguished member of the group and will act as a mentor to the board. Dr. Siegall will continue his innovative progress and will help develop Mirna Therapeutics in both the science aspect of the company as well as in the business side of the company.

Mirna is a company that, like Seattle Genetics, specializes in biotechnology and ingenuity. With some of the top experts in the oncology department involved with the creation of a great product to help with the body, Mirna is truly and innovative company that will prove to help the lives of many individuals on the way to success. The goal of these biotechnology companies is to target to cancerous cells directly without harming the good cells within the body. This means no side effects will be involved with the treatment that are often associated with radiation as well as with chemotherapy.

http://www.bloomberg.com/research/stocks/people/person.asp?personId=607509&privcapId=34145

http://www.xconomy.com/author/csiegall/

Dr. Clay Siegall Leads the Way

Seattle Genetics is making great strides towards becoming one of the top oncology multi-product companies worldwide. They have many clinical trials currently underway and are showing great promise with upcoming trials being planned for the near future. The financial outlook for the company is strong with net sales continuing to rise.

Seattle Genetics (SGEN) Clay B. Siegall on Q2 2016 Results – Earnings Call Transcript

Seattle Genetics base their company around the biotechnology principle of using organisms and cells for product development. Their goal is to help patients that have been diagnosed with cancer live longer healthier lives. They use antibody-drug conjugates, or ADCs, to target cancer cells. This has proven to be effective for both cancer and autoimmune diseases.

Leading the Way

Clay Siegall is the Chief Executive Officer, Chairman of the Board, and President of Seattle Genetics. He has been the guiding force behind raising the capital that was needed to move the company forward. Dr. Siegall received a Bachelor of Science degree in Zoology from the University of Maryland and a Ph.D. in Genetics at George Washington University. His work experience has paved a path to where he is today including Bristol-Myers Squibb Pharmaceutical Research Institute, National Cancer Institute, National Institute of Health, and has served on several boards.

Awards and Accolades

Clay B. Siegall accomplishments can be seen in the number of awards he has received such as the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year and the 2013 University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences. He is the holder of over 15 patents and is an accomplished writer having been published in over 70 publications.

Helping Others

Dr. Siegall’s passion to help others was the driving force he needed to help found Seattle Genetics. He encourages innovation, research, and drug development practices within the company. Seattle Genetics is continuing to grow by expanding their product lines. People all over the world are now able to benefit from the hard work and dedication of Dr. Siegall and his associates. Giving people hope for the future is something that Seattle Genetics and Clay Siegall are striving to accomplish.

http://seekingalpha.com/article/3969434-seattle-genetics-sgen-clay-b-siegall-q1-2016-results-earnings-call-transcript

http://executives.findthecompany.com/l/23957/Dr-Clay-B-Siegall-PhD

Seattle Genetics a Leader in Scientific Innovation

Seattle Genetics is perhaps one of the lesser known innovators in the scientific world. Under the leadership of Clay Siegall, the company has grown to be a lot more than just a whisper in the wind. Siegall founded Seattle Genetics in 1998. Siegall is a trained scientist and specialized in cancer research. When he founded Seattle genetics, he wanted them to be a leader in innovation as well as research that was described as rigorous and overall a sense of wanting to help others to live a better and more productive life.

Siegall and his team help to develop antibody drug conjugates. This development helped later on to lead to the 2011 approval of their first ADC product named ADCETRIS. It has went on to become approved in more than 60 countries and has helped to put Siegall and Seattle Genetics in the public eye. With his leadership, Seattle Genetics has been able to partner with a number of manufacturers including Genentech, GlaxoSmithCline as well as Pfizer and have generated more than 300 million to date.

Using Seattle Genetics technology through a series of collaborations there are more than 20 ADC’s currently in development. Siegall has also been responsible for a large amount of capital fund raising totaling around 1.2 billion that was secured through a series of public and private fund raising. Before founding Seattle genetics, Clay Siegal was active with a number of companies, in the medical industry. Before he started his career, Siegal received a Ph.D in genetics from George Washington University and a degree in zoology from the University of Maryland.

With Clay Siegall’s leadership and the technological advances that Seattle Genetics are making, it is easy to see how this will lead to there being a lot of advances in the coming years that will hopefully help to conquer a number of the diseases that have been plaguing us all these years.

Seattle Genetics: Leading the Way in Antibody-Drug Conjugates

Seattle Genetics is a biotech company on a mission to provide the world with the finest antibody-based therapies for cancer treatment. Their research focuses on using monoclonal antibodies to target cancer cells while avoiding doing damage to other cells within the body. The kinds of drugs they work on are called antibody-drug conjugates, or ADCs for short. They hope that their drugs will be able to save many patients from having to undergo often hazardous chemotherapy procedures in the future.

The best known drug put out by Seattle Genetics is called ADCETRIS. This cancer-fighting drug is currently available in over 60 countries. The team at Seattle Genetics hopes they can strengthen this drug with further research to treat different kinds of lymphoma in the near future.

Currently Clay Siegall is the CEO and President of Seattle Genetics. Dr. Siegall also co-founded this company back in 1998.

Dr. Siegall earned his B. S. in Zoology from the University of Maryland. After that, he was awarded his Ph.D. in Genetics at George Washington University.

After graduating from college, Dr. Siegall worked for many prestigious institutions. Dr. Siegall worked at both Bristol-Myers’ Squibb Pharmaceutical Research Institute and the National Cancer Institute before forming Seattle Genetics. In addition to his post as the head of Seattle Genetics, Dr. Siegall is on the Boards of Directors of many other companies, including Ultragenyx Pharmaceutical, Mirna Therapeutics, and Alder BioPharmaceuticals.

In creating Seattle Genetics, Dr. Siegall wished to create a company that had a rigorous work ethic, an encouraging atmosphere for innovation, and a clear awareness of the patients they are serving. Thus far, Dr. Siegall has led his company towards many lucrative alliances with major players in the pharma world, including Pfizer, AbbVie, and GlaxoSmithKline.

For all of his work in both research and development of ADCs, Dr. Siegall has been given many awards in recent years. Dr. Siegall was recently given an alumni award from his alma mater the University of Maryland. Dr. Siegall also recognized as the Pacific Northwest Ernst & Young Entrepreneur of 2012.

Learn More

http://www.seattlegenetics.com/clay_siegall

http://seekingalpha.com/article/3969434-seattle-genetics-sgen-clay-b-siegall-q1-2016-results-earnings-call-transcript